Episode Transcript
Transcripts are displayed as originally observed. Some content, including advertisements may have changed.
Use Ctrl + F to search
0:00
Try This from The Washington Post is
0:02
a new series of audio courses that
0:04
takes on life's everyday challenges. I'm
0:07
Christina Quinn, and I'll help you find
0:09
real guidance with practical, easy enough approaches
0:11
that won't feel like the advice you
0:14
hear everywhere else. Each audio
0:16
course will have anywhere from two to five classes
0:18
on things like how to get better sleep, how
0:20
to get the most out of your relationships, and
0:22
even how to get out of your own way.
0:25
Find Try This from The Washington Post,
0:27
wherever you listen. Try
0:30
This from The Washington Post, wherever you listen. I
1:00
support a limited number of
1:02
prescription drugs from Canada. Daniel
1:06
Gilbert covers the business of medicine for The
1:08
Post. He says this decision
1:10
from the Food and Drug Administration is
1:12
part of a bigger push to bring
1:14
down drug prices for everything
1:17
from cancer to mental health conditions.
1:20
The idea of importing drugs much
1:23
less expensively from Canada
1:25
has animated politicians
1:28
and regular
1:30
American consumers for a couple of
1:32
decades now. This decision
1:34
by FDA for
1:36
the first time creates a pathway
1:39
for states to actually buy
1:41
prescription drugs in bulk from Canada that could
1:43
be a potentially very significant cost savings for
1:46
them. But
1:48
if other states get a green light to
1:50
buy medicine from Canada, that country
1:52
could risk running out of its own
1:54
supplies. So it's really not
1:56
clear what will happen if those two things
1:58
collide. From
2:04
the newsroom of the Washington Post, this
2:06
is Post Reports. I'm
2:08
Elahe Izadi. It's Monday,
2:10
January 8th. Today, Daniel
2:12
explains why, for the first time,
2:15
a U.S. state can
2:17
import cheaper medicine from Canada, and
2:19
whether this could change the cost of
2:21
medicine throughout the U.S. Just
2:36
really briefly, one of the
2:38
reasons I think this is catching a lot
2:40
of people's attention is because how much drugs
2:42
cost in the United States, right? Is
2:44
that true? Do they cost a lot in the United States? They
2:47
do, yeah. I mean, it may
2:50
not be a surprise to a lot of
2:52
people that prescription drugs are expensive here, but
2:54
it's actually pretty well documented that drug
2:57
prices in the U.S. are significantly
2:59
higher than in most developed countries
3:02
around the world. There's
3:04
a widely cited study by Rand Corporation from
3:06
2021 that found that Canada's drugs on the
3:10
whole cost about half of what prescription
3:12
drugs in the U.S. cost. And
3:15
what we're really talking about here
3:17
are brand name drugs. The
3:20
brand name drugs are really expensive relative to
3:22
other countries. Daniel, I want
3:24
to understand how we got to this decision
3:26
from the Food and Drug Administration. So
3:29
first, where does this story begin? So
3:33
it goes back to, I would
3:35
say, like the year 2000 as
3:38
a good place to begin. There was a
3:40
law that was enacted that would have allowed
3:42
states to import prescription drugs from other countries,
3:45
but it never really got off
3:47
the ground because of a requirement
3:49
that the Secretary of
3:51
Health and Human Services would
3:53
have to certify that adequate
3:56
safety could be maintained and that... The
4:00
costs of prescription drugs
4:02
could significantly be reduced. And
4:05
there were several secretaries that declined to
4:08
make that determination. And
4:10
so it wasn't until the Trump administration. Thank
4:12
you very much. This is
4:14
a very big announcement.
4:17
Here's been President Trump in 2020. The
4:20
unprecedented reforms we're completing
4:22
today are the direct
4:24
result of the historic drug pricing
4:26
executive orders I signed in July.
4:29
President Trump signed an executive
4:31
order basically saying, ordering
4:35
the completion of a rulemaking process that would
4:37
allow a process for the states to import
4:39
certain prescription drugs from Canada.
4:43
Statutorily, we had to go through a
4:45
very long process. And we got
4:47
it done. I was very proud to have gotten this done.
4:49
We were pushing it very hard. So
4:56
is that where Florida comes into the
4:58
picture? That is where Florida
5:00
comes into picture. That was when Florida
5:02
formally applied to be able to import
5:04
drugs from Canada. After the federal government
5:07
finalized their rule, we submitted
5:09
our Section 804 proposal. This is DeSantis
5:11
in 2021. And when I
5:13
signed the bill, I told people, this is the
5:15
first step. There's a lot of hurdles that you
5:17
have to overcome. But we've been doing
5:20
it every step of the way. And
5:22
after that, there's a 2021
5:25
executive order by President Biden that's
5:27
directing FDA to work with states
5:29
like Florida that wanted to import prescription
5:32
drugs. And at least
5:34
from Florida's perspective, the process did
5:36
not move very quickly. FDA
5:39
had additional questions about Florida's plan.
5:41
Florida would have questions about FDA's
5:44
requests. So there was
5:46
a lot of back and forth. And then it got to
5:49
the point where Florida sued FDA in
5:51
2022 to try to force it to
5:53
rule on its application. And
5:55
this is DeSantis in late 2022. After
5:58
630 days. You know,
6:01
we still sit here waiting for an answer.
6:03
And so it's our view that we've waited
6:05
long enough. And so today
6:07
we're taking action. The state
6:09
of Florida has now filed a
6:11
lawsuit against the FDA. For
6:14
Florida Governor Ron DeSantis, the
6:17
FDA was delaying in an unreasonable
6:19
and reckless way. And
6:21
looking in some of the court filings, you can
6:24
see that some of the
6:26
FDA's concerns are about drug supply
6:28
chain security, cost savings, the
6:30
way that drugs would be labeled, as
6:32
well as some other things. And
6:34
then as of Friday, it looks like Florida finally
6:37
satisfied FDA. So Daniel,
6:39
this has to do with states buying
6:41
drugs, rather than a resident
6:43
in Florida wanting to buy medicine from
6:46
Canada, right? So tell me
6:48
why states are buying drugs and why would
6:50
they want to buy them directly from Canada?
6:53
Well, really for the same reason that people
6:55
want to buy drugs from Canada, and it's
6:57
to save money. And
6:59
medical tourism has been a thing for
7:02
a while. But
7:04
a state couldn't just take
7:07
a little trip across the border and bring back
7:09
some drugs. There wasn't any mechanism
7:11
for that. And so this proposal
7:13
from Florida is about
7:15
creating that mechanism so that
7:18
they can get certain prescription drugs in bulk, that
7:20
they would then be able to use for Floridians
7:23
initially in the care of
7:25
state-run facilities, and then eventually
7:27
to expand that to state Medicaid recipients.
7:30
I see. So with state, this might seem
7:32
obvious to you, but for me, I'm like,
7:34
oh, why is a state buying drugs? And
7:36
it's because they have these drugs in state-run
7:38
facilities and eventually Medicaid patients.
7:41
That that's what these bulk drugs would
7:43
be used for, right? Sure. Daniel,
7:47
what are some drugs that
7:50
and the types of treatment that they offer that
7:52
the price could drop
7:54
for Floridians? So what the
7:56
state of Florida hasn't publicly said, specific
7:59
drugs? But what they've generally described
8:01
is seeking drugs that
8:03
would treat conditions like mental
8:05
health, HIV,
8:08
AIDS, prostate cancer,
8:11
some common conditions. So
8:13
why are drugs cheaper in Canada?
8:15
What makes Canada different? Canada
8:18
is different because Canada has done the
8:20
work to regulate prices of prescription drugs
8:22
lower. There's a board
8:24
that regulates the price of brand name
8:27
patented drugs in Canada to determine whether
8:29
the prices are excessive. And
8:32
if it does determine they're excessive, can actually order a manufacturer
8:34
to lower the price of a drug. The
8:36
U.S. doesn't have that. In
8:38
the U.S., the manufacturer, the patent holder of
8:41
the drug gets to charge
8:43
what they want to charge, what they
8:45
think the market will bear, until they
8:47
lose the exclusivity of their patents and
8:50
then generic drug makers
8:52
can offer cheaper alternatives, which brings
8:55
down the price. Why can't
8:57
the U.S. do something like Canada and
8:59
have a system that is like Canada?
9:01
What are some of the barriers to
9:03
that or the forces allied against that?
9:06
Okay, well, it's been a difficult proposition over
9:08
the years. The
9:11
pharmaceutical industry is not
9:14
thrilled about the various
9:17
proposals to lower prescription drug pricing
9:20
in the U.S. And
9:23
one of the arguments that the
9:25
pharmaceutical industry and some others like
9:27
patient advocacy groups make
9:30
is that developing new drugs
9:32
is extremely difficult. It's expensive,
9:34
it's risky, lots of drugs
9:36
fail, clinical trials
9:38
that the manufacturers pursue
9:41
to either prove or condemn
9:44
how the drugs work takes a lot of time, can
9:46
cost tens or hundreds of millions of dollars. And
9:49
so manufacturers
9:52
that are taking on this risk say they
9:54
need an incentive to get paid for their
9:56
innovation and the risk they're taking on. prescription
12:00
drugs, you can kind of see why that
12:03
would be a popular idea and
12:05
not particularly partisan one. This
12:08
has been an important issue that's come
12:10
up in campaigns over the years as a significant
12:12
part of Bernie Sanders'
12:14
presidential campaign. U.S. presidential
12:16
hopeful Bernie Sanders didn't hold
12:19
back when criticizing the pharmaceutical
12:21
industry. So you got greed,
12:23
you got corruption, and you got kids
12:26
not taking the medicine they need. On
12:29
his bus, insulin-seeking Americans had
12:31
story after story of struggling
12:33
with the cost of living
12:35
with diabetes. The
12:37
Trump administration comes in and Trump
12:40
signs an executive order. The Biden
12:42
administration comes in and Biden signs
12:45
an executive order to direct
12:47
the FDA to work with states to
12:49
make this happen. But
12:51
that struggle continues, by the way.
12:53
And certainly, like, the Biden administration
12:55
has prioritized this, like, seen this
12:57
as a really important
13:00
issue to try to
13:02
tamp down these rising
13:05
prescription drug prices. And
13:07
the biggest thing that they have done
13:09
is the Inflation Reduction Act. Yeah,
13:12
Daniel, can you tell me more about what
13:14
the Biden administration has done so far? Well,
13:18
the Biden administration continued in a
13:20
way what the Trump administration started
13:22
with an executive order directing FDA
13:25
to work with states that
13:27
wanted to import drugs from
13:30
Canada or abroad. The
13:32
Biden administration has also taken
13:35
on this more ambitiously, really,
13:38
than administrations in
13:40
recent memory in enacting the
13:42
Inflation Reduction Act. And
13:44
this is like a frontal effort
13:47
to directly lower drug prices in the
13:49
U.S. This is like the very thing
13:51
that they're trying to cure by importing
13:53
drugs from Canada. But
13:55
this is more of a head-on way of approaching
13:57
it and something more similar to what Canada has
13:59
done. done with setting maximum
14:01
prices. And so the
14:04
Inflation Reduction Act would cap how
14:06
much Medicare pays drug makers
14:08
for certain drugs that Medicare spends a lot
14:10
of money on. In October,
14:13
the administration announced the first 10 drugs
14:16
that will be subject to these maximum
14:19
prices. And today I'm proud to
14:21
announce that Medicare has selected the first
14:23
10 additional drugs for
14:25
negotiation under the Inflation Reduction Act. Here's
14:28
President Biden in late 2023. Medicare
14:31
spends $50 billion
14:33
a year on these 10
14:35
drugs. And American seniors
14:38
are spending $3.4 billion on
14:41
out-of-pocket costs. And
14:43
the idea with the Inflation
14:45
Reduction Act and this provision is
14:47
to add more drugs
14:49
that are subject to price caps over
14:52
time. But it's going to be quite a few
14:54
years before any
14:56
cost savings are really realized
14:58
from those efforts. And there's also litigation
15:00
from drug makers and
15:05
the pharmaceutical industry to try
15:08
to neutralize that effort too. So
15:18
Daniel, how has the pharmaceutical industry
15:21
responded to not just this ruling, but
15:23
all the pressure that
15:25
it has received to reduce costs? They've
15:29
responded with a pretty ferocious
15:33
legal attack. They
15:35
see this as risk to the business
15:37
in different ways. And
15:39
so there's been a
15:41
pretty organized forceful response from
15:44
the pharmaceutical industry to try to neutralize
15:47
the Inflation Reduction Act or
15:49
to try to prevent drug
15:52
importation from getting off the ground. In fact,
15:55
the Pharmaceutical Research and Manufacturers of America,
15:57
this is a big lobby.
16:00
called Pharma. It sued
16:02
FDA over the drug importation plan
16:04
and there was a judge who
16:07
ruled in February that the association
16:09
lacked standing because
16:12
they didn't face a concrete risk of
16:14
harm at that point. But
16:16
now that the FDA has given Florida
16:18
the green light, that
16:21
conceivably has made things more concrete so it
16:23
wouldn't be surprising to see more litigation going
16:26
forward. But there are other
16:28
ways that kind of
16:31
indicate that pharmaceutical companies
16:33
are acknowledging the public
16:35
pressure to lower drug
16:37
prices. And
16:39
so last year one of the things that
16:41
we saw was initially
16:44
Eli Lilly, a pharmaceutical
16:46
company in the US, slashed the
16:49
price of its influence. 70% capped
16:51
the cost of their insulin
16:54
at like $35 a month now.
16:58
And that was after a period of years where the price
17:00
of insulin had gone up and up. That
17:02
was an acknowledgement that there was a
17:04
need to lower those prices and that
17:06
was followed by the two
17:08
other big insulin
17:11
makers, Sanofi and
17:13
Novo Nordisk following suit and
17:16
also dramatically lowering the
17:18
cost of their insulin and those prices took
17:20
effect this month. So
17:23
Daniel, in addition to what
17:25
the pharmaceutical industry is doing to
17:27
push back against these efforts
17:30
and then also at the same time
17:32
some of these companies acknowledging the high
17:34
cost, when we talk about their
17:37
argument as to why the
17:39
FDA should not be
17:41
allowing the importation of medicines, what argument are
17:44
they making? Because I think the average person
17:46
would say, well are they just making
17:49
this argument because this is a threat
17:51
to their bottom line? What
17:55
is their argument that they're making? Today,
18:01
the US actually
18:04
does import a significant
18:06
amount of drugs from
18:08
foreign manufacturers. And
18:11
the process for that is that companies,
18:14
manufacturers around the world, notably
18:17
in India and China, they
18:19
will register with the FDA, say, we
18:22
are going to manufacture these drugs and
18:24
FDA will go and inspect
18:26
those facilities and make sure that
18:29
they meet all the
18:31
stringent requirements that FDA would require of
18:33
facilities in the US. So there already
18:35
is a process in which we get
18:38
a lot of drugs from
18:40
other countries. But
18:43
what is different here is
18:46
that states are
18:48
now kind of trying to take this process
18:50
in their own hands and find a foreign
18:53
seller, like a company in
18:56
Canada that will sell drugs
18:58
to Floridians. And
19:01
they have to find a logistics company that will
19:04
handle the importation and they have to
19:06
find a way to distribute all these drugs. And
19:08
there are various requirements they have to meet from
19:10
FDA. But the central
19:12
concern is if drugs
19:15
are entering the US delivery
19:17
system from another point that
19:20
maybe hasn't gone
19:22
through the same process as
19:26
FDA registered and inspected
19:28
manufacturers, there could
19:31
be some amount of risk
19:33
for unsafe drugs or counterfeit drugs
19:35
to enter the system. And that is one point that
19:38
the pharmaceutical industry has made. But it's also a
19:40
point that the FDA itself
19:42
has raised this concern to try to make sure
19:46
that the integrity of the drug
19:48
supply chain is protected and there's
19:50
no additional risk to Americans. So
19:53
in this case, what would Florida have to do to make sure
19:55
that these imported medications
19:57
that it's safe? There is
19:59
a lot. a long list of requirements that
20:02
Florida has to do, even
20:04
now, even after getting this approval
20:07
from FDA to actually
20:10
physically import these
20:12
drugs. And they have
20:14
to tell FDA like the
20:16
specific drugs that they are
20:18
attempting to import. They
20:21
have to be able to tell FDA
20:23
who made the raw ingredients used in
20:25
the drugs. They have to provide proof
20:28
of the Canadian company that's
20:31
selling them the drugs, obtain them from
20:33
the manufacturer, the batch numbers, lot numbers,
20:35
a description of how they will be
20:37
tested, who will do the testing. So
20:40
there's a lot, still like a lot of
20:43
information that Florida has to provide to FDA.
20:47
So this decision, do you
20:50
anticipate it benefiting other
20:52
states and patients anytime soon? What will
20:54
you be looking to in the future
20:57
on this issue? I
21:01
think it'll benefit other states in the
21:04
sense that it provides an example for how
21:06
this can be done. As
21:09
far as whether it'll benefit patients soon, that
21:12
depends on a few things. Depends
21:18
on Florida satisfying additional requirements
21:20
from FDA, prerequisites
21:22
to importing the drugs physically,
21:25
but also the
21:27
uncertainties about what kind
21:29
of curbs Canada might impose
21:31
on its domestic supply of medicines.
21:33
Canada's pretty concerned that
21:36
the US importing in bulk
21:38
from Canada could cause drug
21:40
shortages. And there could
21:43
also be legal challenges that might
21:45
delay this from moving forward. Thank
21:51
you so much for joining me today. Thank
21:54
you for having me. Daniel
22:01
Gilbert writes about the business of medicine for
22:03
The Post. That's it for
22:05
Post Reports. Thanks for listening.
22:08
Today's show was produced by Bishop Zant. It
22:11
was mixed by Reni Svinofsky and edited
22:14
by Monica Campbell. Thanks
22:16
to Alana Gordon and Sandhya Somashaker.
22:21
Before you go, I wanted to tell you about
22:23
something new from The Post. It's
22:25
called Try This, and it's The
22:27
Washington Post's first ever audio course.
22:30
If you love the episodes of Post
22:32
Reports where we talk to reporters about
22:34
practical tips that can help us all
22:37
live better lives, then you'll definitely appreciate
22:39
Try This. Check it out. I'm
22:42
Elahe Izadi. We'll be back tomorrow
22:44
with more stories from The Washington Post. When
23:09
it comes to teaching kids and teens about
23:12
money, practice makes perfect. That's where
23:14
Greenlight comes in. With a debit
23:16
card and money app of their own, kids
23:18
learn to earn, save, spend wisely, and invest.
23:21
Parents send instant money transfers, create
23:23
custom chores, and automate allowance, while
23:25
kids track their spending, set savings
23:27
goals, and practice money skills they
23:29
can use today and for
23:31
life. Get one month free when
23:33
you sign up at greenlight.com slash podcast.
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More